Lifestyle
- Increase physical activity
- Quit smoking
- Maintain healthy weight
High-Density Lipoprotein · HDL-C · HDL
HDL-C quantifies the amount of cholesterol transported by high-density lipoproteins in the blood.
Reference ranges may vary slightly by lab; generally, higher HDL-C is better.
High-Density Lipoprotein Cholesterol (HDL-C) is a type of cholesterol carried by high-density lipoproteins in the blood. It is often referred to as 'good' cholesterol because it helps transport cholesterol from other parts of the body back to the liver, where it can be processed and excreted. This process is crucial for maintaining lipid balance and preventing cholesterol accumulation in blood vessels. Clinically, HDL-C is important as it is inversely associated with the risk of atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease, peripheral vascular disease, and cerebrovascular disease. Low levels of HDL-C are linked to an increased risk of these conditions, while higher levels are generally protective. Additionally, researchers have found that HDL-C levels may also be inversely related to cancer incidence and progression, although the mechanisms are not fully understood. For athletes and biohackers, maintaining optimal HDL-C levels is important for cardiovascular health and longevity. HDL-C is involved in anti-inflammatory and antioxidant processes, which can support recovery and performance. However, it is important to note that HDL-C levels can be influenced by factors such as genetics, diet, physical activity, and certain medications. Fasting is not required for HDL-C testing, but levels can be affected by recent intense exercise or acute illness, which should be considered when interpreting results.
Klinische Bedeutung
Elevated HDL-C levels are generally protective against cardiovascular diseases, while low levels are associated with increased risk. HDL-C may also have a role in cancer prognosis.
Progressively rising HDL-C values suggest improved cardiovascular protection. Re-test annually unless clinically indicated otherwise.
Progressively falling HDL-C values may indicate increased cardiovascular risk.
Re-test Interval
6 months if outside optimal range
Note:
Consult a healthcare provider before starting new supplements, especially if on medication.
Testing Frequency
Annually for adults, more frequently if managing cardiovascular risk.
Current research suggests that the molecular mechanisms linking HDL-C to tumor incidence and prognosis remain understudied, with conflicting views on its role in cancer. Researchers have not yet established optimal reference ranges or targets for HDL-C in various populations, particularly concerning metabolic syndrome and cardiovascular disease risk. Additionally, clinical questions regarding the impact of HDL-C levels on outcomes in specific conditions like obstructive sleep apnea and gout remain unanswered.
530
Total Citations
7
Human/RCT
3.0
Avg. Influence
2021
Latest
Researchers found that the ratio of triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) is a promising biomarker for predicting the risk of metabolic syndrome and cardiovascular disease. The study highlights the importance of monitoring both triglycerides and HDL-C levels, even when low-density lipoprotein cholesterol is well-managed. This ratio may provide valuable insights into cardiovascular health.
Researchers found a positive correlation between high-density lipoprotein cholesterol (HDL-C) levels and lumbar bone mineral density (BMD) in adults aged 20-59. The study highlighted that this relationship varies by sex and race, suggesting that HDL-C could serve as a biomarker for early detection of osteoporosis.
This study investigated hypertriglyceridemia in obese children and adolescents, focusing on the TG/HDL-C ratio as a marker of cardiometabolic risk. Researchers found that elevated TG levels are common in this population and recommended lifestyle modifications to manage triglyceride levels.
This review analyzed the role of high-density lipoprotein cholesterol (HDL-C) in colorectal cancer (CRC). Researchers found that HDL-C levels decrease in CRC patients, and emphasized the need for further studies on HDL functionality and its potential as a biomarker in CRC.
This review focused on the relationship between high-density lipoprotein (HDL) and cancer, particularly in endocrine carcinomas. Researchers observed that HDL-C levels may inversely correlate with cancer risk and suggested potential therapeutic applications of synthetic HDL in cancer treatment.
Researchers reviewed the role of high-density lipoprotein cholesterol (HDL-C) in age-related ocular diseases. The review summarizes current knowledge regarding HDL-C's potential involvement in conditions such as age-related macular degeneration and diabetic retinopathy, although specific mechanisms remain unclear.
Researchers reviewed novel recombinant high-density lipoprotein formulations as potential therapies for cardiovascular disease. The study highlights the need for further clinical trials to evaluate the effectiveness of these HDL-modifying therapies in reducing atherosclerotic events.
Researchers examined the association between high-density lipoprotein cholesterol (HDL-C) levels and cancer outcomes. The findings suggest a negative correlation between HDL-C and tumor incidence, indicating that higher HDL-C levels may be linked to better cancer prognosis. However, the study calls for further investigation into the molecular mechanisms behind this relationship.
Researchers explored the relationship between the platelet-to-high-density lipoprotein cholesterol ratio (PHR) and bone mineral density (BMD). The study identified a nonlinear, inverted U-shaped relationship, indicating that maintaining optimal PHR levels is important for supporting bone health, particularly in high-risk populations.
Researchers investigated the relationship between the non-high-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio (NHHR) and gout prevalence. The study revealed that higher NHHR levels are significantly associated with increased odds of developing gout, suggesting that NHHR may be a useful marker for assessing gout risk in adults.
Research publications about HDL-Cholesterin over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer